Tasimelteon

( DrugBank: Tasimelteon / KEGG DRUG: Tasimelteon )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
202	スミス・マギニス症候群	2

202. スミス・マギニス症候群

臨床試験数 : 9 / 薬物数 : 10 - (DrugBank : 5) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 7

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02776215 (ClinicalTrials.gov)	September 2016	16/5/2016	Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents	Open-label Study to Investigate the Pharmacokinetics and Safety of Tasimelteonin Children and Adoles ...	Circadian Rhythm Sleep Disorders;Non-24 Hour Sleep-Wake Disorder;Autism Spectrum Disorder;Smith-Mage ...	Drug: tasimelteon	Vanda Pharmaceuticals	NULL	Recruiting	3 Years	17 Years	All	24	Phase 1	United States
2	NCT02231008 (ClinicalTrials.gov)	September 2015	29/8/2014	Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS	A Double-blind, Randomized, Two-period Crossover Study Evaluating the Effects of Tasimelteonvs. Plac ...	Smith-Magenis Syndrome;Circadian	Drug: tasimelteon;Drug: placebo	Vanda Pharmaceuticals	NULL	Completed	3 Years	65 Years	All	49	Phase 2/Phase 3	United States

First Previous1Next Last